This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
We’re excited to share that metaMe Health , a prescription digitaltherapeutics (PDT) company, today announced raising $2.2M Ken Greisman , the HPA Deal Lead and a veteran of the pharmaceutical industry, has joined the metaMe board of directors. in funding. and chief legal officer at Takeda Pharmaceuticals U.S.A.,
We’re excited to share that metaMe Health , a prescription digitaltherapeutics (PDT) company, today announced raising $2.2M Ken Greisman , the HPA Deal Lead and a veteran of the pharmaceutical industry, has joined the metaMe board of directors. in funding. and chief legal officer at Takeda Pharmaceuticals U.S.A.,
The post [DarioHealth in PR Newswire] Diabetes and Behavioral Health Global Experts Join DarioHealth Scientific Advisory Board Expanding Innovation Leadership in DigitalTherapeutics for Chronic Care D appeared first on OurCrowd Blog. Read more here.
TEL AVIV, Israel, April 26, 2022 /PRNewswire/ — Sweetch, a digitaltherapeutics innovator and creator of the precision engagement platform for chronic conditions, announced today that Robert A. The post [Sweetch in PR Newswire] Sweetch Strengthens its Advisory Board with Appointment of Diabetes Care Leader, Dr. Robert A.
Register Biofourmis , a Sigapore-founded digitaltherapeutics firm , announced that it has surpassed unicorn status with a $300 million Series D investment led by leading global growth equity firm General Atlantic. Bookmark ( 0 ) Please login to bookmark Username or Email Address Password Remember Me No account yet?
16, 2022 Sweetch, a digitaltherapeutics innovator and creator of the precision engagement platform for chronic conditions, announced today that Fatima Cody Stanford MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS has joined the company as an advisor. TEL AVIV, Israel, Nov. Read more on PR Newswire here.
(Nasdaq: DRIO), a pioneer in the global digitaltherapeutics market, today announces that Eric Milledge has joined DarioHealth as Chairman of the company’s newly-established Scientific Advisory Board (SAB). Read more here.
a multi-billion-dollar diabetes franchise previously owned by Johnson & Johnson (JNJ) Scientific Advisory Board will help develop and execute the Company’s strategic roadmap for refining, improving and expanding its digitaltherapeutics platform. Read more here.
MedRhythms, a Portland, Maine-based digitaltherapeutics company, is building direct stimulation, prescription therapeutics that use sensors, music, and software to improve loss of mobility caused by neurologic injuries and diseases. How does MedRhythms’ technology work?
Whether you’re pursuing an IND or an IDE, you’ll have to fully explain what you want to study, who your investigators are, how safe the product is, what type of patient consent you’re requesting, and what institutional review board (IRB) has reviewed and cleared your studies. Marketing Approval.
We organize all of the trending information in your field so you don't have to. Join 24,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content